These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 30801691)

  • 1. Signalling in response to sub-picomolar concentrations of active compounds: Pushing the boundaries of GPCR sensitivity.
    Civciristov S; Halls ML
    Br J Pharmacol; 2019 Jul; 176(14):2382-2401. PubMed ID: 30801691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPCR signalling from within the cell.
    Jong YI; Harmon SK; O'Malley KL
    Br J Pharmacol; 2018 Nov; 175(21):4026-4035. PubMed ID: 28872669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.
    Klonisch T; Glogowska A; Thanasupawat T; Burg M; Krcek J; Pitz M; Jaggupilli A; Chelikani P; Wong GW; Hombach-Klonisch S
    Br J Pharmacol; 2017 May; 174(10):1025-1033. PubMed ID: 27443788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor.
    Ang SY; Hutchinson DS; Patil N; Evans BA; Bathgate RAD; Halls ML; Hossain MA; Summers RJ; Kocan M
    Br J Pharmacol; 2017 May; 174(10):1077-1089. PubMed ID: 27243554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superagonism at G protein-coupled receptors and beyond.
    Schrage R; De Min A; Hochheiser K; Kostenis E; Mohr K
    Br J Pharmacol; 2016 Oct; 173(20):3018-27. PubMed ID: 26276510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unravelling G protein-coupled receptor signalling networks using global phosphoproteomics.
    Pokhrel R; Morgan AL; Robinson HR; Stone MJ; Foster SR
    Br J Pharmacol; 2024 Jul; 181(14):2359-2370. PubMed ID: 36772927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating the GPCR transactivation-dependent and biased signalling paradigms in the context of PAR1 signalling.
    Little PJ; Hollenberg MD; Kamato D; Thomas W; Chen J; Wang T; Zheng W; Osman N
    Br J Pharmacol; 2016 Oct; 173(20):2992-3000. PubMed ID: 26624252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biased agonists of GPR84 and insights into biological control.
    Luscombe VB; Wang P; Russell AJ; Greaves DR
    Br J Pharmacol; 2024 May; 181(10):1509-1523. PubMed ID: 38148720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.
    Ma S; Smith CM; Blasiak A; Gundlach AL
    Br J Pharmacol; 2017 May; 174(10):1034-1048. PubMed ID: 27774604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current state of GPCR-based drug discovery to treat metabolic disease.
    Sloop KW; Emmerson PJ; Statnick MA; Willard FS
    Br J Pharmacol; 2018 Nov; 175(21):4060-4071. PubMed ID: 29394497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of β-adrenoceptors up-regulates cardiac expression of galectin-3 and BIM through the Hippo signalling pathway.
    Zhao WB; Lu Q; Nguyen MN; Su Y; Ziemann M; Wang LN; Kiriazis H; Puthalakath H; Sadoshima J; Hu HY; Du XJ
    Br J Pharmacol; 2019 Jul; 176(14):2465-2481. PubMed ID: 30932177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pharmacology of GPCRs.
    Langmead CJ; Summers RJ
    Br J Pharmacol; 2018 Nov; 175(21):4005-4008. PubMed ID: 30302756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias.
    Sengmany K; Gregory KJ
    Br J Pharmacol; 2016 Oct; 173(20):3001-17. PubMed ID: 26276909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPCRs in context: sexual dimorphism in the cardiovascular system.
    Mouat MA; Coleman JLJ; Smith NJ
    Br J Pharmacol; 2018 Nov; 175(21):4047-4059. PubMed ID: 29451687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPR84 in physiology-Many functions in many tissues.
    Aktar R; Rondinelli S; Peiris M
    Br J Pharmacol; 2024 May; 181(10):1524-1535. PubMed ID: 37533166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular insights into orphan G protein-coupled receptors relevant to schizophrenia.
    Lu Y; Hatzipantelis CJ; Langmead CJ; Stewart GD
    Br J Pharmacol; 2024 Jul; 181(14):2095-2113. PubMed ID: 37605621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenoceptors-New roles for old players.
    Michel MC; Bond RA; Summers RJ
    Br J Pharmacol; 2019 Jul; 176(14):2339-2342. PubMed ID: 31240712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying ligands at orphan GPCRs: current status using structure-based approaches.
    Ngo T; Kufareva I; Coleman JLj; Graham RM; Abagyan R; Smith NJ
    Br J Pharmacol; 2016 Oct; 173(20):2934-51. PubMed ID: 26837045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of artificial intelligence to accelerate G protein-coupled receptor drug discovery.
    Nguyen ATN; Nguyen DTN; Koh HY; Toskov J; MacLean W; Xu A; Zhang D; Webb GI; May LT; Halls ML
    Br J Pharmacol; 2024 Jul; 181(14):2371-2384. PubMed ID: 37161878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of RGS proteins in cardiometabolic disease.
    McNeill SM; Zhao P
    Br J Pharmacol; 2024 Jul; 181(14):2319-2337. PubMed ID: 36964984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.